166 related articles for article (PubMed ID: 12860856)
1. Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure.
Androne AS; Hryniewicz K; Goldsmith R; Arwady A; Katz SD
Heart; 2003 Aug; 89(8):854-8. PubMed ID: 12860856
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure.
Serra SM; Costa RV; Teixeira De Castro RR; Xavier SS; Nóbrega AC
J Card Fail; 2009 Mar; 15(2):124-9. PubMed ID: 19254671
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Heart; 2004 Oct; 90(10):1119-23. PubMed ID: 15367503
[TBL] [Abstract][Full Text] [Related]
4. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.
Dewland TA; Androne AS; Lee FA; Lampert RJ; Katz SD
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H86-92. PubMed ID: 17322413
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
[TBL] [Abstract][Full Text] [Related]
6. Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease.
Castro RR; Serra SM; Porphirio G; Mendes FS; Oliveira LP; Nóbrega AC
Int J Cardiol; 2006 Feb; 107(1):138-9. PubMed ID: 16337518
[TBL] [Abstract][Full Text] [Related]
7. Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats.
Bharadwaj M; Pope C; Davis M; Katz S; Cook C; Maxwell L
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):872-879. PubMed ID: 28440910
[TBL] [Abstract][Full Text] [Related]
8. Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine.
Serra SM; Costa RV; Bastos BG; Bousquet Santos K; Ramalho SH; da Nóbrega AC
Arq Bras Cardiol; 2001 Apr; 76(4):279-84. PubMed ID: 11323731
[TBL] [Abstract][Full Text] [Related]
9. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study.
Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.
Nóbrega AC; dos Reis AF; Moraes RS; Bastos BG; Ferlin EL; Ribeiro JP
Clin Auton Res; 2001 Feb; 11(1):11-7. PubMed ID: 11503945
[TBL] [Abstract][Full Text] [Related]
11. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure.
Lataro RM; Silva CA; Fazan R; Rossi MA; Prado CM; Godinho RO; Salgado HC
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R908-16. PubMed ID: 23948774
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure.
Shibao C; Okamoto LE; Gamboa A; Yu C; Diedrich A; Raj SR; Robertson D; Biaggioni I
Hypertension; 2010 Nov; 56(5):847-51. PubMed ID: 20837887
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholinesterase inhibition in patients with orthostatic intolerance.
Singer W; Opfer-Gehrking TL; Nickander KK; Hines SM; Low PA
J Clin Neurophysiol; 2006 Oct; 23(5):476-81. PubMed ID: 17016160
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome.
Raj SR; Black BK; Biaggioni I; Harris PA; Robertson D
Circulation; 2005 May; 111(21):2734-40. PubMed ID: 15911704
[TBL] [Abstract][Full Text] [Related]
15. Effect of pyridostigmine on the exercise-heat response of man.
Epstein Y; Arnon R; Moran D; Seidman DS; Danon Y
Eur J Appl Physiol Occup Physiol; 1990; 61(1-2):128-32. PubMed ID: 2289489
[TBL] [Abstract][Full Text] [Related]
16. Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects.
Sant'anna ID; de Sousa EB; de Moraes AV; Loures DL; Mesquita ET; da Nóbrega AC
Clin Sci (Lond); 2003 Aug; 105(2):161-5. PubMed ID: 12627998
[TBL] [Abstract][Full Text] [Related]
17. The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure.
Sabino JP; da Silva CA; de Melo RF; Fazan R; Salgado HC
Auton Neurosci; 2013 Jan; 173(1-2):58-64. PubMed ID: 23218833
[TBL] [Abstract][Full Text] [Related]
18. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine.
Joseph P; Pari R; Miller S; Warren A; Stovall MC; Squires J; Chang CJ; Xiao W; Waxman AB; Systrom DM
Chest; 2022 Nov; 162(5):1116-1126. PubMed ID: 35526605
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibition reduces arrhythmias in asymptomatic Chagas disease.
Castro RRT; Porphirio G; Xavier SS; Moraes RS; Ferlin EL; Ribeiro JP; da Nóbrega ACL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28715142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
